宫内节育器使用与卵巢癌风险:系统综述与Meta分析
该研究通过系统检索MEDLINE、EMBASE、Cochrane图书馆、Web of Science核心合集(自建库至2018年6月)及ClinicalTrials.gov,纳入15项具有个体水平数据的病例对照和队列研究,其中11项用于Meta分析。数据协调加权后,曾使用宫内节育器与卵巢癌发病风险的汇总OR为0.68(95%CI 0.62-0.75),各协变量间无显著差异,研究间异质性I²=68%。结论认为基于现有回顾性数据,宫内节育器使用与卵巢癌发病率降低相关,但关于宫内节育器在卵巢癌预防中作用的前瞻性研究有限。
要点
- 曾使用宫内节育器与卵巢癌发病风险降低相关,汇总OR为0.68(95%CI 0.62-0.75)。
- 各协变量间未发现显著差异,研究间异质性I²=68%。
- 结论基于现有回顾性数据,前瞻性研究证据有限。
核心结论
- 基于现有回顾性数据,宫内节育器使用与卵巢癌发病率降低相关。
- 关于宫内节育器在卵巢癌预防中作用的前瞻性研究有限。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、EMBASE、Cochrane图书馆、Web of Science核心合集(自建库至2018年6月)及ClinicalTrials.gov。
- 从399篇文献摘要及Google Scholar额外200篇文章中识别出15项具有个体水平数据的病例对照和队列研究,最终11项纳入Meta分析。
- 排除所有病例报告和综述。
主要发现
- 数据协调加权后,曾使用宫内节育器与卵巢癌发病风险的汇总OR为0.68(95%CI 0.62-0.75)。
- 各协变量间未发现显著差异。
- 所有研究间异质性I²=68%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 结论基于现有回顾性数据。
- 关于宫内节育器在卵巢癌预防中作用的前瞻性研究有限。
- 研究间异质性I²=68%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the relationship between intrauterine device (IUD) use and risk of ovarian cancer through systematic review of the literature and meta-analysis. DATA SOURCES: We searched MEDLINE, EMBASE, Cochrane Library, Web of Science Core Collection from inception to June 2018. For the MEDLINE search, we included the MeSH terms "intrauterine devices" AND "ovarian neoplasms," however also searching "intrauter*," "ovar*" and "fallopian tube," as well as "cancer" and "carcinoma" as keywords to include all possible variations. Similar search terms were used in the other databases. We also searched ClinicalTrials.gov. METHODS OF STUDY SELECTION: Case-control and cohort studies that collected individual level data on IUD use and ovarian cancer diagnosis were critically reviewed and data extracted. Review of abstracts from 399 articles through systematic database review and an additional 200 articles through Google Scholar identified a total of 15 studies with individual level data regarding IUD use and incident ovarian cancer. On critical review, 11 of these studies were used for meta-analysis. All case reports and reviews were excluded. TABULATION, INTEGRATION, AND RESULTS: The data were harmonized and weighted and summary odds ratios (ORs) were calculated. Covariates were identified evaluated separately. A random-effects meta-analysis was performed to confirm minimal bias. Harmonization and weighting of the data revealed an OR association between ever use of an IUD and incident ovarian cancer to be 0.68 (95% CI 0.62-0.75). There were no significant differences found between covariates. Heterogeneity among all studies was found to be I=68%. CONCLUSION: Intrauterine device use is associated with a reduced incidence of ovarian cancer based on a review of existing retrospective data. Unfortunately, prospective investigation into the role of IUDs in ovarian cancer prevention is limited.
引用
- Wheeler LJ, Desanto K, Teal SB, et al. Intrauterine Device Use and Ovarian Cancer Risk: A Systematic Review and Meta-analysis. Obstet Gynecol. 2019. PMID: 31503144. doi:10.1097/AOG.0000000000003463
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。